Samia Mora

Research interests

Publications

• Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac361

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

  Atherosclerosis · 2020 · https://doi.org/10.1016/j.atherosclerosis.2019.12.005

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

  Clinical Chemistry and Laboratory Medicine (CCLM) · 2019 · https://doi.org/10.1515/cclm-2019-1253

• Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1809944

• Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1811403

• Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31652-0

• Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

  Clinical Chemistry · 2018 · https://doi.org/10.1373/clinchem.2018.287037

• Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints—A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

  Clinical Chemistry · 2016 · https://doi.org/10.1373/clinchem.2016.258897

• Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

  European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw152

• Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

  Science · 2016 · https://doi.org/10.1126/science.aad3517

• A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians

  PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0120758

• Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events

  Journal of the American College of Cardiology · 2014 · https://doi.org/10.1016/j.jacc.2014.02.615

• Common variants associated with plasma triglycerides and risk for coronary artery disease

  Nature Genetics · 2013 · 10.1038/ng.2795

• Discovery and refinement of loci associated with lipid levels

  Nature Genetics · 2013 · 10.1038/ng.2797

• Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

  JAMA · 2012 · https://doi.org/10.1001/jama.2012.366

• Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children

  PLoS Medicine · 2011 · https://doi.org/10.1371/journal.pmed.1001116

• Physical Activity and Reduced Risk of Cardiovascular Events

  Circulation · 2007 · https://doi.org/10.1161/circulationaha.107.729939

• Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women

  JAMA · 2007 · https://doi.org/10.1001/jama.298.3.309

Current projects

No projects listed.